Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers.
Hodges HC, Stanton BZ, Cermakova K, Chang CY, Miller EL, Kirkland JG, Ku WL, Veverka V, Zhao K, Crabtree GR
Nat Struct Mol Biol. 2018 Jan;25(1):61-72. doi: 10.1038/s41594-017-0007-3. Epub 2017 Dec 11.
(Link opens in a new window)
PubMed
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 107056 | WT Smarca4-sfGFP | Expression of wild-type Smarca4 (Brg1) with C-terminal super-folder GFP fusion. |
| 107057 | K785R Smarca4-sfGFP | Expression of dominant-negative K785R Smarca4 (Brg1) with C-terminal super-folder GFP fusion. |
| 107058 | WT Smarca4-V5 IRES-puro | Expression of wild-type Smarca4 (Brg1)-V5 fusion with IRES puromycin resistance. |
| 107059 | K785R Smarca4-V5 IRES-puro | Expression of dominant-negative K785R Smarca4 (Brg1)-V5 fusion with IRES puromycin resistance. |